Drug search by name

Baci-IM injection and Dehydration

Result of checking the interaction of drug Baci-IM injection and disease Dehydration for safety when used together.

Check result:

Baci-IM injection <> Dehydration

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Adequate hydration is crucial to minimize the risk of nephrotoxicity associated with the systemic use of bacitracin. Dehydration should preferably be corrected prior to initiation of therapy. In patients who may be at risk for dehydration, such as those with severe and/or prolonged diarrhea or vomiting, fluid status should be monitored closely. If signs of renal irritation develop during therapy, hydration should be increased as indicated, accompanied by a reduction in dosage if necessary. Therapy should be withdrawn if urinary output decreases progressively or azotemia increases.

References:

"Product Information. Bacitracin (bacitracin)." Pharmacia and Upjohn, Kalamazoo, MI.
American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association; (1994):

Baci-IM injection

Generic Name: bacitracin

Brand Name: Baci-IM, Baci-Rx

Synonyms: Baci-IM (injection), BACiiM

What is Baci-IM injection?